Issue 10/2023
Content (33 Articles)
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'
Stefano Boschi, Sergio Todde
Defining the role of nuclear medicine in haematological tumours—EANM Focus 4: consensus on molecular imaging and therapy in haematological tumours
Cristina Nanni, Carsten Kobe, Ken Herrmann, Jolanta Kunikowska
PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL)
Niek H. J. Prakken, Florent L. Besson, Ronald J. H. Borra, Florian Büther, Ronny R. Buechel, Ciprian Catana, Arturo Chiti, Rudi A. J. O. Dierckx, Marc R. Dweck, Paola A. Erba, Andor W. J. M. Glaudemans, Lars C. Gormsen, Ivalina Hristova, Michel Koole, Thomas C. Kwee, Felix M. Mottaghy, Irene Polycarpou, Mathias Prokop, Lars Stegger, Charalampos Tsoumpas, Riemer H. J. A. Slart
Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best?
Rubel Chakravarty, Wenyu Song, Sudipta Chakraborty, Weibo Cai
PET imaging of tumor vascular normalization in hepatocellular carcinoma
Shuxian An, Jianjun Liu, Gang Huang, Fei Kang, Weijun Wei
GCP III is not the “off-target” for urea-based PSMA ligands
Zhenghong Lee, Warren D. Heston, Xinning Wang, James P. Basilion
Response to: GCP III is not the “off-target” for urea-based PSMA-ligands
Gabriele Bassi, Samuele Cazzamalli, Sebastian Oehler, Laura Lucaroni, Tony Georgiev, Nicholas Favalli, Dario Neri
Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands
Steve S. Huang, Frank DiFilippo, Daniel Lindner, Warren D. W. Heston
Preclinical evaluation of 68Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma
Huawei Cai, Zhao Li, Qiuxiao Shi, Hao Yang, Liu Xiao, Mufeng Li, Hua Lin, Xiaoai Wu, Tianshan She, Lihong Chen, Lin Li, Xiaofeng Lu
In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain
Xuefeng Yan, Fabrice G. Siméon, Jeih-San Liow, Cheryl L. Morse, Jose A. Montero Santamaria, Madeline Jenkins, Lester S. Manly, Maia Van Buskirk, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis, Paolo Zanotti-Fregonara
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
Audrey Mauguen, Ravinder K. Grewal, Finn Augensen, Murad Abusamra, Sonia Mahajan, Vetri Sudar Jayaprakasam, Joseph Osborne, Sofia Haque, Bernadette Z. Y. Wong, Ronald A. Ghossein, James Fagin, Heiko Schӧder, R. Michael Tuttle, Alan Ho, John L. Humm, Steven M. Larson
The predictive value of pretherapy [68Ga]Ga-DOTA-TATE PET and biomarkers in [177Lu]Lu-PRRT tumor dosimetry
Azadeh Akhavanallaf, Avery B. Peterson, Kellen Fitzpatrick, Molly Roseland, Ka Kit Wong, Issam El-Naqa, Habib Zaidi, Yuni K. Dewaraja
The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with 177Lu DOTATATE (LuTate)
R. Alipour, P. Jackson, M. Bressel, A. Hogg, J. Callahan, R. J. Hicks, G. Kong
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors
Aleksander Kosmala, Sebastian E. Serfling, Kerstin Michalski, Thomas Lindner, Andreas Schirbel, Takahiro Higuchi, Philipp E. Hartrampf, Thorsten Derlin, Andreas K. Buck, Alexander Weich, Rudolf A. Werner
A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support
Fernando de A. Fernandes, Kristoffer Larsen, Zhuo He, Erivelton Nascimento, Amalia Peix, Qiuying Sha, Diana Paez, Ernest V. Garcia, Weihua Zhou, Claudio T. Mesquita
Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus
Barbara Katharina Geist, Helmut Brath, Lucia Zisser, Josef Yu, Barbara Fueger, Lukas Nics, Eva Maria Patronas, Alexandra Kautzky-Willer, Marcus Hacker, Sazan Rasul
FAP expression in alpha cells of Langherhans insulae—implications for FAPI radiopharmaceuticals’ use
Margarita Kirienko, Giovanni Centonze, Giovanna Sabella, Mauro Sollai, Martina Sollini, Xiaoli Lan, Haojun Chen, Luigi Terracciano, Ettore Seregni, Massimo Milione
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides
Jacopo Millul, Lennart Koepke, Gaonkar Raghuvir Haridas, Konstantin M. J. Sparrer, Rosalba Mansi, Melpomeni Fani
Melanin-targeted [18F]-PFPN PET imaging for prognosticating patients with melanoma
Xiao Zhang, Zhaoguo Lin, Mengting Li, Yongkang Gai, Huaiyuan Zheng, Li Fan, Weiwei Ruan, Fan Hu, Jing Chen, Xiaoli Lan
Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[18F] fluoro-L-ascorbic acid PET imaging: first-in-human study
Yali Long, Chang Yi, Renbo Wu, Yuying Zhang, Bing Zhang, Xinchong Shi, Xiangsong Zhang, Zhihao Zha
Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models
Simon Boeke, René M. Winter, Sara Leibfarth, Marcel A. Krueger, Gregory Bowden, Jonathan Cotton, Bernd J. Pichler, Daniel Zips, Daniela Thorwarth
[18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastoma
Peipei Wang, Tuo Li, Zhikai Liu, Mei Jin, Yan Su, Jingjing Zhang, Hongli Jing, Hongming Zhuang, Fang Li
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma
Xiang Zhou, Yongquan Hu, Hong Sun, Ruohua Chen, Gang Huang, Jianjun Liu
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma
Wenjia Zhu, Xiaoyuan Li, Guoyang Zheng, Chunmei Bai, Zhigang Ji, Haiqiong Zhang, Haiqun Xing, Yushi Zhang, Li Huo
A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
Guochang Wang, Linlin Li, Ming Zhu, Jie Zang, Jiarou Wang, Rongxi Wang, Weigang Yan, Lin Zhu, Hank F. Kung, Zhaohui Zhu
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer
Urs J. Muehlematter, Lilit Schweiger, Daniela A. Ferraro, Thomas Hermanns, Tobias Maurer, Matthias M. Heck, Niels J. Rupp, Matthias Eiber, Isabel Rauscher, Irene A. Burger
Bladder paraganglioma detection with [18F]MFBG PET/CT: a superior alternative to [68Ga]Ga-DOTATATE
Peipei Wang, Tuo Li, Fang Li, Jingjing Zhang, Hongli Jing
Metastatic melanoma extending along the inferior vena cava to its branches and venous plexus: a rare route metastasis characterized by [18F]FDG PET/CT
Wenlan Zhou, Xiangzhao Li, Hubing Wu
Sarcoidosis mimicking nodal manifestations of marginal zone lymphoma
Johanna S. Enke, Nic G. Reitsam, Tina Schaller, Rainer Claus, Constantin Lapa, Alexander Dierks
A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans
Claire Leroy, Sébastien Goutal, Louise Breuil, Philippe Gervais, Hamza Cherkaoui, Philippe Ciuciu, Sylvain Auvity, Dominique Vodovar, Claude Comtat, Vincent Lebon, Michel Bottlaender, Nicolas Tournier
Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma
Alessio Imperiale, Miriam Pepponi, Nathan Poterszman, Abhishek Jha, Cedric Collen, Daniel Brumaru, Marie-Pierre Chenard, David Taïeb, Karel Pacak, Bernard Goichot
Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry
Jonathan Gear, Caroline Stokke, Christelle Terwinghe, Silvano Gnesin, Mattias Sandström, Johannes Tran‑Gia, Marta Cremonesi, Francesco Cicone, Fredrik Verburg, Roland Hustinx, Luca Giovanella, Ken Herrmann, Pablo Minguez Gabiña
Correction to: One‑stop [18F]FDG and [68Ga]Ga‑DOTA‑FAPI‑04 total‑body PET/CT examination with dual‑low activity: a feasibility study
Guobing Liu, Wujian Mao, Haojun Yu, Yan Hu, Jianying Gu, Hongcheng Shi